Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study
Monoamine oxidases (MAOs) catalyze the degradation of a very broad range of biogenic and dietary amines including many neurotransmitters in the brain, whose imbalance is extensively linked with the biochemical pathology of various neurological disorders, and are, accordingly, used as primary pharmac...
Main Authors: | Tana Tandarić, Alja Prah, Jernej Stare, Janez Mavri, Robert Vianello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/17/6151 |
Similar Items
-
Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
by: Makoto Naoi, et al.
Published: (2022-09-01) -
Computational Insights into β-Carboline Inhibition of Monoamine Oxidase A
by: Alja Prah, et al.
Published: (2022-10-01) -
Why Monoamine Oxidase B Preferably Metabolizes <i>N</i>-Methylhistamine over Histamine: Evidence from the Multiscale Simulation of the Rate-Limiting Step
by: Aleksandra Maršavelski, et al.
Published: (2022-02-01) -
Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline
by: Laszlo G. Harsing, et al.
Published: (2023-08-01) -
Monoaminergic and histaminergic strategies and treatments in brain diseases
by: Giuseppe Di Giovanni, et al.
Published: (2016-11-01)